Theriva Biologics, Inc.

Theriva Biologics, Inc.verified

TOVX

Price:

$0.3038

Market Cap:

$10.84M

Theriva Biologics Inc. is a clinical-stage biotechnology firm dedicated to developing novel treatments for conditions with significant unmet medical needs. The company's pipeline features several promising candidates, including SYN-004, which is engineered to break down commonly used intravenous beta-lactam antibiotics in the gastrointestinal tract. This degradation aims to avert microbiome damage, Clostridioides difficile infection (CDI), the overgrowth of harmful organisms, the rise of antimicrobial resistance (AMR), and acute graft-versus-host disease (aGVHD) in patients undergoing allogeneic hematopoietic cell transplants. Another key investigational therapy is SYN-020, an orally adminis...[Read more]

Industry

Biotechnology

IPO Date

2006-12-18

Stock Exchange

AMEX

Ticker

TOVX

The Enterprise Value as of June 2026 (TTM) for Theriva Biologics, Inc. (TOVX) is -1521880.00

According to Theriva Biologics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1521880.00. This represents a change of -68.52% compared to the average of -4835042.03 of the last 4 quarters.

Theriva Biologics, Inc. (TOVX) Historical Enterprise Value (quarterly & annually)

How has TOVX Enterprise Value performed in the past?

The mean historical Enterprise Value of Theriva Biologics, Inc. over the last ten years is 451.94M. The current -1521880.00 Enterprise Value has changed -133.67% with respect to the historical average. Over the past ten years (40 quarters), TOVX's Enterprise Value was at its highest in in the June 2016 quarter at 4.08B. The Enterprise Value was at its lowest in in the December 2022 quarter at -32951109.70.

Quarterly (TTM)
Annual

Average

451.94M

Median

117.31M

Minimum

-33134166.70

Maximum

1.78B

Theriva Biologics, Inc. (TOVX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Theriva Biologics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 333.15%

Maximum Annual Enterprise Value = 1.78B

Minimum Annual Increase = -104.34%

Minimum Annual Enterprise Value = -33134166.70

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-7872597.352.44%
2024-7684779.50-45.50%
2023-14100000.00-57.45%
2022-33134166.70-104.34%
2021763.56M333.15%
2020176.28M-9.13%
2019194.00M232.55%
201858.34M-96.38%
20171.61B-9.20%
20161.78B-61.33%

Theriva Biologics, Inc. (TOVX) Average Enterprise Value

How has TOVX Enterprise Value performed in the past?

The current Enterprise Value of Theriva Biologics, Inc. (TOVX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-9885792.28

5-year avg

140.15M

10-year avg

451.94M

Theriva Biologics, Inc. (TOVX) Enterprise Value vs. Peers

How is TOVX’s Enterprise Value compared to its peers?

Theriva Biologics, Inc.’s Enterprise Value is less than Galmed Pharmaceuticals Ltd. (-631711.00), less than BioVie Inc. (-510061.00), less than NKGen Biotech, Inc. Common Stock (46.02M), greater than PMGC Holdings Inc. (-3550215.00), less than Moolec Science S.A. (251.67M), greater than iSpecimen Inc. (-2182129.00), less than Windtree Therapeutics, Inc. (13.40M), greater than BriaCell Therapeutics Corp. Warrant (-1755654.17), less than Chemomab Therapeutics Ltd. (4.25M), greater than Carisma Therapeutics, Inc. (-1759745.00),

Build a custom stock screener for Theriva Biologics, Inc. (TOVX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theriva Biologics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theriva Biologics, Inc. (TOVX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theriva Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Theriva Biologics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Theriva Biologics, Inc. (TOVX)?

What is the 3-year average Enterprise Value for Theriva Biologics, Inc. (TOVX)?

What is the 5-year average Enterprise Value for Theriva Biologics, Inc. (TOVX)?

How does the current Enterprise Value for Theriva Biologics, Inc. (TOVX) compare to its historical average?